MAPT and Alzheimer disease: These results are particularly important since this is the first neurophysiological study on donepezil in a transgenic AD model that contains both amyloid plaques and hyperphosphorylated tau [14], allowing us to determine some of its effects under pathologies paralleling human AD that cannot be readily examined in patients with conventional EEG recording.